Bernhard GÜNTHER,Frank LÖSCHER,Hartmut VOSS,Sonja KRÖSSER,Kirsten EICKHOFF,Daniela WILLEN,Markus BEIER,Thomas SCHLÜTER
申请号：
US16753701
公开号：
US20200268682A1
申请日:
2018.10.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides methods of treatment using ophthalmic compositions comprising semifluorinated alkanes for keratoconjunctivitis sicca and/or Meibomian gland dysfunction, which methods provide for the enrichment of an ophthalmic tissue in the semifluorinated alkane, and optionally methods of delayed release of the semifluorinated alkane from the enriched ophthalmic tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.
